NK012

DRUG3 trials

Sponsors

Nippon Kayaku Co., Ltd.

Conditions

CancerSmall Cell Lung CancerTriple Negative Breast Cancer

Phase 1

Study of NK012 in Patients With Refractory Solid Tumors

CompletedNCT00542958

Nippon Kayaku Co., Ltd.Cancer

Start: 2007-03-31End: 2011-12-31Updated: 2019-10-28

Phase 2

A Study of NK012 in Patients With Advanced, Metastatic Triple Negative Breast Cancer

CompletedNCT00951054

Nippon Kayaku Co., Ltd.Triple Negative Breast Cancer

Start: 2009-02-28End: 2015-02-28Target: 61Updated: 2015-02-16

A Study of NK012 in Patients With Relapsed Small Cell Lung Cancer

CompletedNCT00951613

Nippon Kayaku Co., Ltd.Small Cell Lung Cancer

Start: 2009-07-31Updated: 2013-03-20